Article
A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 May 2004
Ewart-Toland Amanda, Chan June M, Yuan Jinwei, Balmain Allan, Ma Jing
Abstract excerpt
Transforming growth factor beta (TGFbeta) is known to exert both positive and negative effects on different stages of tumor formation. Of the TGFbetaisoforms, TGFbeta1 is highly expressed in prostate cancer and leads to tumor promotion and metastasis. Increased expression of TGFbeta1 is associated with more aggressive tumors and poor prognosis. Several polymorphisms in TGFB1 have been identified, and two variants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
